http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101494231-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-056 |
| filingDate | 2008-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101494231-B1 |
| titleOfInvention | Antiviral compound |
| abstract | The present invention provides a novel class of compounds that exhibit an inhibitory effect on neuraminidase (NA), hemagglutinin (HA), and viral retention structural M 2 proteins. These compounds are also useful as inhibitors of replication factors of hepatitis B virus type C (HVC). The present invention also describes a pharmaceutical composition containing a compound of the present invention, alone or in combination with a suitable, pharmaceutically acceptable carrier. n n Inhibitors of replication factors of neuraminidase (NA), hemagglutinin (HA), hepatitis virus type C (HVC) |
| priorityDate | 2007-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 308.